Skip to main content
| News

Canton of Basel-Landschaft cuts corporate tax rates

25.11.2019

Corporate tax rates in the canton of Basel-Landschaft will be cut from a maximum of 20.7 percent today to 13.45 percent in 2025. This has been stipulated by the proposed Tax Regulation 17, which was approved on Sunday.

Business location Baselland (img: Schärli Hölstein)

Corporate tax rates in the canton of Basel-Landschaft will be cut markedly. The proposed Tax Regulation 17 stipulates that tax on earnings is to be reduced in five steps from the maximum level of 20.7 percent today to 13.45 percent by 2025. Tax on capital will be halved for all companies from the current level of 3.8 per thousand to 1.6 per thousand. In addition, the canton is to introduce a patent box for earnings generated by patents and similar rights; this will offer relief of up to 90 percent. Moreover, an additional discount of 20 percent is offered to research and development activities. At the same time, the tax cut for childcare offered by third parties has been increased to 10,000 Swiss francs and cantonal funding for premiums with individual reductions has been raised by 17.4 million francs.

On Sunday, a clear majority of 63.2 percent of voters approved the proposed tax regulation. In the district of Arlesheim (a suburb of Basel), the majority even hit 66.3 percent. The new cantonal tax regulation implements the Federal Act on Tax Reform and OASI Funding approved by the Swiss people back in May. This will eliminate the previous tax benefits for holding companies. Before, companies benefitting from this fiscal circumstance had been paying 10-11 percent in tax on earnings.

The Basel Chamber of Commerce (HKBB) welcomed the results of voting. “Voters in the Basel-Landschaft area have recognized that the taxation proposal strengthens the region”, HKBB Director Martin Dätwyler commented in a press release. The broad level of support from parties and associations all the way down to individual municipalities shows that a proposal had been negotiated that would command a majority.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area Business & Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

South Korean pharma firms show interest in the Basel Area

Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...

Read More
Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

KetoSwiss secures capital increase of 4 million dollars

KetoSwiss has banked a total of 4 million US dollars from investors. The Basel-based startup develops products to alleviate neurological...

Read More
Basel Area Business & Innovation, Invest, Life Sciences / biotech

Escientia Switzerland becomes Primopus

The Indian company Deccan Fine Chemicals is acquiring Escientia Switzerland and renaming it as Primopus AG. The new owner announces...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Novartis investing 100 million Swiss francs in new biologics center

The pharmaceutical company Novartis is investing a sum of 100 million Swiss francs in a new competence center for biologics...

Read More
1 2 3 35

Do you have a question? We'd like to hear from you.